AR015470A1 - Acido beta-arilo-alfa-alquilcarboxilico, su uso para la manufactura de un medicamento, procedimientos para su preparacion, composiciones farmaceuticas quelos contienen, compuestos intermediarios y procedimiento para su preparacion - Google Patents
Acido beta-arilo-alfa-alquilcarboxilico, su uso para la manufactura de un medicamento, procedimientos para su preparacion, composiciones farmaceuticas quelos contienen, compuestos intermediarios y procedimiento para su preparacionInfo
- Publication number
- AR015470A1 AR015470A1 ARP980105382A ARP980105382A AR015470A1 AR 015470 A1 AR015470 A1 AR 015470A1 AR P980105382 A ARP980105382 A AR P980105382A AR P980105382 A ARP980105382 A AR P980105382A AR 015470 A1 AR015470 A1 AR 015470A1
- Authority
- AR
- Argentina
- Prior art keywords
- preparation
- unsubstituted
- derivatives
- groups
- alkoxy
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
- C07C323/62—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/42—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C235/44—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring
- C07C235/48—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring having the nitrogen atom of at least one of the carboxamide groups bound to an acyclic carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C327/00—Thiocarboxylic acids
- C07C327/38—Amides of thiocarboxylic acids
- C07C327/48—Amides of thiocarboxylic acids having carbon atoms of thiocarboxamide groups bound to carbon atoms of six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
- C07D239/88—Oxygen atoms
- C07D239/90—Oxygen atoms with acyclic radicals attached in position 2 or 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D265/04—1,3-Oxazines; Hydrogenated 1,3-oxazines
- C07D265/12—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems
- C07D265/14—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D265/20—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with hetero atoms directly attached in position 4
- C07D265/22—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D279/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
- C07D279/04—1,3-Thiazines; Hydrogenated 1,3-thiazines
- C07D279/08—1,3-Thiazines; Hydrogenated 1,3-thiazines condensed with carbocyclic rings or ring systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Acidos beta-arilo-alfa-alquilcarboxílicos oxisubstituidos, antiobesidad e hipocolesterolémicos, que tienen la formula general (I), a sus derivados, a susanálogos, a sus formas tautoméricas, a sus estereoisomeros, a sus polimorfos, a sus sales farmaceuticamente aceptable, a sus solvatos farmacéuticamenteaceptables, donde X representa O o S; los grupos R1, R2, R3, R4 y los grupos R5 y R6 cuando están unidos al átomo de C pueden ser iguales o diferentes yrepresentan hidrogeno, halogeno, hidroxi, ciano, nitro, formilo; o grupos no sustituidos o sustituidos seleccionados de alquilo, cicloalquilo, alcoxi,cicloalcoxi, arilo, ariloxi, aralquilo, aralcoxi, heterociclilo, heteroarilo, heteroariloxi, heteroaralquilo, heteroaralcoxi, acilo, aciloxi, alcoxicarbonilo,ariloxicarbonilo, aralcoxicarbonilo, amino, alquilamino que puede ser un grupo mono o dialquilamino, arilamino, acilamino, aralquilamino, aminoalquilo,hidroxialquilo, alcoxialquilo, ariloxialquilo, aralcoxialquilo, tioalquilo, alquiltio, alcoxicarbonilamino, ariloxicarbonilamino, aralcoxicarbonilamino, ácidocarboxílico o sus derivados o ácido sulfonico o sus derivados; W representa O, S, o un grupo NR11; R11 y los grupos R5 y R6 cuando están unidos al átomo denitrogeno pueden ser iguales o diferentes y representan hidrogeno, hidroxi, formilo o grupos no sustituidos o sustituidos seleccionados de alquilo,cicloalquilo, alcoxi, cicloalcoxi, arilo, aralquilo, ariloxi, aralcoxi, heterociclilo, heteroarilo, heteroariloxi, heteroaralquilo, heteroaralcoxi, acilo,aciloxi, hidroxialquilo, amino, acilamino, alquilamino que puede ser un grupo mono o dialquilamino, arilamino, aralquilamino, aminoalquilo, alcoxicarbonilo,ariloxicarbonilo, aralcoxiacarbonilo,alcoxialquilo, ariloxialquilo, aralcoxialquilo, alquiltio, tioalquilo, derivados de ácido carboxílico o derivados de ácidosulfonico; n es un numero entero comprendido entre 1-4; Ar representa un grupo aromático o heterocíclico divalente no sustituido o sustituido; R7 representaunátomo de hidrogeno, hidroxi, alcoxi, halogeno, alquilo inferior o un grupo aralquilo no sustituido o sustituido o forma un enlace con R8; R8 representa un
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN2419MA1997 | 1997-10-27 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR015470A1 true AR015470A1 (es) | 2001-05-02 |
Family
ID=11096893
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP980105382A AR015470A1 (es) | 1997-10-27 | 1998-10-27 | Acido beta-arilo-alfa-alquilcarboxilico, su uso para la manufactura de un medicamento, procedimientos para su preparacion, composiciones farmaceuticas quelos contienen, compuestos intermediarios y procedimiento para su preparacion |
Country Status (8)
Country | Link |
---|---|
US (3) | US6130214A (es) |
EP (1) | EP1124807A1 (es) |
CN (1) | CN1280574A (es) |
AR (1) | AR015470A1 (es) |
AU (1) | AU1198699A (es) |
MY (1) | MY121760A (es) |
WO (1) | WO1999016758A1 (es) |
ZA (1) | ZA989790B (es) |
Families Citing this family (73)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2307068C (en) | 1997-10-27 | 2007-04-10 | Dr. Reddy's Research Foundation | Bicyclic compounds, process for their preparation and pharmaceutical compositions containing them |
US6440961B1 (en) | 1997-10-27 | 2002-08-27 | Dr. Reddy's Research Foundation | Tricyclic compounds and their use in medicine: process for their preparation and pharmaceutical compositions containing them |
AU2192000A (en) * | 1998-12-17 | 2000-07-03 | Mindset Biopharmaceuticals (Usa) Inc. | Increasing brain glucose utilization |
AR022204A1 (es) | 1999-01-08 | 2002-09-04 | Norgine Bv | Compuesto, proceso para su preparacion, composicion farmaceutica y producto comestible que lo comprende. |
WO2000063193A1 (en) * | 1999-04-16 | 2000-10-26 | Dr. Reddy's Research Foundation | Novel polymorphic forms of an antidiabetic agent: process for their preparation and a pharmaceutical composition containing them |
US7414128B2 (en) | 1999-04-20 | 2008-08-19 | Dr. Reddy's Laboratories, Limited | Crystalline R-guanidines, Arginine or (L)-Arginine (2S)-2-Ethoxy-3-{4-[2-(10H -phenoxazin-10-yl)ethoxy]phenyl}propanoate |
WO2000063153A1 (en) * | 1999-04-20 | 2000-10-26 | Novo Nordisk A/S | New compounds, their preparation and use |
US6972294B1 (en) | 1999-04-20 | 2005-12-06 | Novo Nordisk, A/S | Compounds, their preparation and use |
US6369055B1 (en) | 1999-04-20 | 2002-04-09 | Novo Nordisk A/S | Compounds, their preparation and use |
AU3957900A (en) * | 1999-04-20 | 2000-11-02 | Novo Nordisk A/S | New compounds, their preparation and use |
EP1171438A1 (en) * | 1999-04-20 | 2002-01-16 | Novo Nordisk A/S | Compounds, their preparation and use |
US6274608B1 (en) | 1999-04-20 | 2001-08-14 | Novo Nordisk A/S | Compounds, their preparation and use |
ES2287016T3 (es) | 1999-04-28 | 2007-12-16 | Sanofi-Aventis Deutschland Gmbh | Derivados de diaril-acido como ligandos del receptor ppar. |
US6414002B1 (en) | 1999-09-22 | 2002-07-02 | Bristol-Myers Squibb Company | Substituted acid derivatives useful as antidiabetic and antiobesity agents and method |
TW200528436A (en) | 1999-09-22 | 2005-09-01 | Bristol Myers Squibb Co | Substituted acid derivatives useful as antiodiabetic and antiobesity agents and method |
CZ20011872A3 (cs) | 1999-09-29 | 2002-03-13 | Ortho-Mcneil Pharmaceutical, Inc. | Isonipekotamidy pro léčbu onemocnění zprostředkovaných integriny |
CA2397828C (en) * | 2000-01-19 | 2007-09-04 | Cadila Healthcare Ltd. | Compounds having hypolipidemic and hypocholesteremic activities, process for their preparation and pharmaceutical compositions containing them |
WO2001055085A1 (en) * | 2000-01-28 | 2001-08-02 | Novo Nordisk A/S | Propionic acid derivatives and their use in the treatment of diabetes and obesity |
US6569901B2 (en) | 2000-01-28 | 2003-05-27 | Novo Nordisk A/S | Alkynyl-substituted propionic acid derivatives, their preparation and use |
US6555577B1 (en) | 2000-01-28 | 2003-04-29 | Novo Nordisk A/S | Compounds, their preparation and use |
US6509374B2 (en) | 2000-04-17 | 2003-01-21 | Novo Nordisk A/S | Compounds, their preparation and use |
JP2004529918A (ja) * | 2001-04-09 | 2004-09-30 | オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド | インテグリンに由来する疾患の治療のためのキナゾリンおよびキナゾリン類似化合物 |
TWI311133B (en) | 2001-04-20 | 2009-06-21 | Eisai R&D Man Co Ltd | Carboxylic acid derivativeand the salt thereof |
US6486127B1 (en) * | 2001-05-23 | 2002-11-26 | Insmed, Incorporated | Compositions comprising D-chiro inositol and lipid lowering compounds and methods of treatment thereof |
JPWO2002098840A1 (ja) | 2001-06-04 | 2004-09-16 | エーザイ株式会社 | カルボン酸誘導体及びその塩もしくはそのエステルからなる医薬 |
WO2003002508A1 (en) * | 2001-06-28 | 2003-01-09 | Dr. Reddy's Research Foundation | Derivatives of para-ethoxy-phenillactic acid |
US6987123B2 (en) | 2001-07-26 | 2006-01-17 | Cadila Healthcare Limited | Heterocyclic compounds, their preparation, pharmaceutical compositions containing them and their use in medicine |
US6869967B2 (en) | 2001-07-30 | 2005-03-22 | Novo Nordisk A/S | Peroxisome proliferator-activated receptor (PPAR) active vinyl carboxylic acid derivatives |
US7067530B2 (en) | 2001-07-30 | 2006-06-27 | Novo Nordisk A/S | Compounds, their preparation and use |
WO2003016265A1 (fr) | 2001-08-17 | 2003-02-27 | Eisai Co., Ltd. | Compose cyclique et agoniste du recepteur ppar |
US7220877B2 (en) | 2001-10-17 | 2007-05-22 | Novo Nordisk A/S | Compounds, their preparation and use |
NZ532368A (en) * | 2001-11-26 | 2006-10-27 | Cortex Pharma Inc | Carbonylbenzoxazine compounds for enhancing glutamatergic synaptic responses |
WO2003059378A2 (en) | 2001-12-29 | 2003-07-24 | Novo Nordisk A/S | Combined use of a glp-1 compound and another drug for treating dyslipidemia |
US7015345B2 (en) | 2002-02-21 | 2006-03-21 | Asahi Kasei Pharma Corporation | Propionic acid derivatives |
WO2004004665A2 (en) | 2002-07-09 | 2004-01-15 | Bristol-Myers Squibb Company | Substituted heterocyclic derivatives useful as antidiabetic and antiobesity agents and method |
US7816385B2 (en) | 2002-12-20 | 2010-10-19 | High Point Pharmaceuticals, Llc | Dimeric dicarboxylic acid derivatives, their preparation and use |
EP1621210B1 (en) * | 2003-04-28 | 2013-06-19 | Daiichi Sankyo Company, Limited | Adiponectin production enhancer |
US7772272B2 (en) * | 2003-04-28 | 2010-08-10 | Daiichi Sankyo Company, Limited | Method for enhancing glucose uptake into warm-blooded animal adipocytes |
US20040248972A1 (en) * | 2003-05-16 | 2004-12-09 | Ambit Biosciences Corporation | Compounds and uses thereof |
JP2007500219A (ja) * | 2003-05-16 | 2007-01-11 | アンビット バイオサイエンシス コーポレーション | 複素環化合物およびその使用法 |
US20050182125A1 (en) * | 2003-05-16 | 2005-08-18 | Ambit Biosciences Corporation | Pyrrole compounds and uses thereof |
US8710045B2 (en) | 2004-01-22 | 2014-04-29 | The Trustees Of Columbia University In The City Of New York | Agents for preventing and treating disorders involving modulation of the ryanodine receptors |
US20080125403A1 (en) | 2004-04-02 | 2008-05-29 | Merck & Co., Inc. | Method of Treating Men with Metabolic and Anthropometric Disorders |
ES2393885T7 (es) | 2007-06-04 | 2014-01-30 | Synergy Pharmaceuticals Inc. | Agonistas de la guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros trastornos |
US8969514B2 (en) | 2007-06-04 | 2015-03-03 | Synergy Pharmaceuticals, Inc. | Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases |
ES2522968T3 (es) | 2008-06-04 | 2014-11-19 | Synergy Pharmaceuticals Inc. | Agonistas de guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros trastornos |
AU2009270833B2 (en) | 2008-07-16 | 2015-02-19 | Bausch Health Ireland Limited | Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders |
MX2011004258A (es) | 2008-10-22 | 2011-06-01 | Merck Sharp & Dohme | Derivados de bencimidazol ciclicos novedosos utiles como agentes anti-diabeticos. |
CA2741672A1 (en) | 2008-10-31 | 2010-05-06 | Merck Sharp & Dohme Corp. | Novel cyclic benzimidazole derivatives useful anti-diabetic agents |
CA2786314A1 (en) | 2010-02-25 | 2011-09-01 | Merck Sharp & Dohme Corp. | Novel cyclic benzimidazole derivatives useful anti-diabetic agents |
WO2012027331A1 (en) | 2010-08-27 | 2012-03-01 | Ironwood Pharmaceuticals, Inc. | Compositions and methods for treating or preventing metabolic syndrome and related diseases and disorders |
US9616097B2 (en) | 2010-09-15 | 2017-04-11 | Synergy Pharmaceuticals, Inc. | Formulations of guanylate cyclase C agonists and methods of use |
UA110813C2 (uk) | 2011-01-31 | 2016-02-25 | Каділа Хелткере Лімітед | Лікування ліподистрофії |
KR101668514B1 (ko) | 2011-02-25 | 2016-10-21 | 머크 샤프 앤드 돔 코포레이션 | 항당뇨병제로서 유용한 신규 시클릭 아자벤즈이미다졸 유도체 |
US20150004144A1 (en) | 2011-12-02 | 2015-01-01 | The General Hospital Corporation | Differentiation into brown adipocytes |
JP2015525782A (ja) | 2012-08-02 | 2015-09-07 | メルク・シャープ・アンド・ドーム・コーポレーションMerck Sharp & Dohme Corp. | 抗糖尿病性三環式化合物 |
EP2900243A4 (en) * | 2012-09-27 | 2016-04-13 | Portola Pharm Inc | BICYCLIC OXA LACTAM KINASE HEMMER |
RU2015140066A (ru) | 2013-02-22 | 2017-03-30 | Мерк Шарп И Доум Корп. | Противодиабетические бициклические соединения |
US9650375B2 (en) | 2013-03-14 | 2017-05-16 | Merck Sharp & Dohme Corp. | Indole derivatives useful as anti-diabetic agents |
JP2016514671A (ja) | 2013-03-15 | 2016-05-23 | シナジー ファーマシューティカルズ インコーポレイテッド | グアニル酸シクラーゼのアゴニストおよびその使用 |
CA2905435A1 (en) | 2013-03-15 | 2014-09-25 | Synergy Pharmaceuticals Inc. | Compositions useful for the treatment of gastrointestinal disorders |
CN105377246B (zh) | 2013-04-22 | 2018-03-20 | 卡迪拉保健有限公司 | 针对非酒精性脂肪性肝病(nafld)的新组合物 |
WO2014195967A2 (en) | 2013-05-30 | 2014-12-11 | Cadila Healthcare Limited | A process for preparation of pyrroles having hypolipidemic hypocholesteremic activities |
US10011637B2 (en) | 2013-06-05 | 2018-07-03 | Synergy Pharmaceuticals, Inc. | Ultra-pure agonists of guanylate cyclase C, method of making and using same |
TW201513857A (zh) | 2013-07-05 | 2015-04-16 | Cadila Healthcare Ltd | 協同性組成物 |
IN2013MU02470A (es) | 2013-07-25 | 2015-06-26 | Cadila Healthcare Ltd | |
US10112898B2 (en) | 2013-09-06 | 2018-10-30 | Cadila Healthcare Limited | Process for the preparation of saroglitazar pharmaceutical salts |
WO2015051496A1 (en) | 2013-10-08 | 2015-04-16 | Merck Sharp & Dohme Corp. | Antidiabetic tricyclic compounds |
US10385017B2 (en) | 2015-10-14 | 2019-08-20 | Cadila Healthcare Limited | Pyrrole compound, compositions and process for preparation thereof |
WO2018106518A1 (en) | 2016-12-06 | 2018-06-14 | Merck Sharp & Dohme Corp. | Antidiabetic heterocyclic compounds |
ES2894261T3 (es) | 2016-12-09 | 2022-02-14 | Cadila Healthcare Ltd | Tratamiento de la colangitis biliar primaria |
US10968232B2 (en) | 2016-12-20 | 2021-04-06 | Merck Sharp & Dohme Corp. | Antidiabetic spirochroman compounds |
CN107056715B (zh) * | 2017-04-07 | 2019-07-30 | 江南大学 | 一种增强TRPV4-KCa2.3复合体耦联度的化合物及其在抗高血压中的应用 |
Family Cites Families (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1445742A1 (de) * | 1963-11-06 | 1968-12-19 | Bayer Ag | Verfahren zur Herstellung von 2-Stellung substituierten Benzoxazinonen |
US3903134A (en) * | 1971-07-21 | 1975-09-02 | Rorer Inc William H | Phenyl propionic acids and derivatives thereof |
GB1537838A (en) * | 1975-06-09 | 1979-01-04 | Takeda Chemical Industries Ltd | Alpha-chlorocarboxylic acids |
JPS60188083A (ja) * | 1984-03-07 | 1985-09-25 | Amano Pharmaceut Co Ltd | カルボン酸置換体の製造法 |
DK173350B1 (da) * | 1985-02-26 | 2000-08-07 | Sankyo Co | Thiazolidinderivater, deres fremstilling og farmaceutisk paæparat indeholdende dem |
CA2035147A1 (en) * | 1990-02-08 | 1991-08-09 | Kousuke Yasuda | Thiazine (or oxazine) derivatives and preparation thereof |
US5089514A (en) * | 1990-06-14 | 1992-02-18 | Pfizer Inc. | 3-coxazolyl [phenyl, chromanyl or benzofuranyl]-2-hydroxypropionic acid derivatives and analogs as hypoglycemic agents |
JPH05194236A (ja) * | 1991-07-25 | 1993-08-03 | Tanabe Seiyaku Co Ltd | 中枢性カルシウム拮抗剤 |
NZ253742A (en) * | 1992-07-03 | 1997-06-24 | Smithkline Beecham Plc | Heterocyclylaminoalkoxy substituted phenyl derivatives and pharmaceutical compositions |
GB9225386D0 (en) * | 1992-12-04 | 1993-01-27 | Smithkline Beecham Plc | Novel compounds |
GB9326171D0 (en) * | 1993-12-22 | 1994-02-23 | Smithkline Beecham Plc | Novel compounds |
BR9508468A (pt) * | 1994-07-29 | 1997-11-25 | Smithkline Beecham Plc | Composto processo para a preparação do mesmo composição farmacéutica processos para o tratamento e/ou profilaxia de hiperglicemia em um mamifero humano ou não humano e para o tratamento de hiperlípidemia hipertensão doença cardiovascular alguns distúrbios de alimentação o tratamento e/ou profilaxia de doença renal a prevenção revers o estabilização ou retardo da progressão de microalbuminuria em um mamifero humano ou não humano uso do composto e composto intermediário |
JPH0912575A (ja) * | 1995-06-28 | 1997-01-14 | Sankyo Co Ltd | ベンゾオキサジンおよびベンゾチアジン誘導体 |
GB9600464D0 (en) * | 1996-01-09 | 1996-03-13 | Smithkline Beecham Plc | Novel method |
CN1190434C (zh) * | 1996-12-31 | 2005-02-23 | 雷迪实验室有限公司 | 新的杂环化合物、其制备方法和含有它们的药物组合物及其在治疗糖尿病和相关疾病中的应用 |
EP0903343B1 (en) * | 1997-09-19 | 2003-05-28 | SSP Co., Ltd. | Alpha-Substituted phenylpropionic acid derivative and medicine containing the same |
SE9801992D0 (sv) * | 1998-06-04 | 1998-06-04 | Astra Ab | New 3-aryl-2-hydroxypropionic acid derivative I |
SE9801990D0 (sv) * | 1998-06-04 | 1998-06-04 | Astra Ab | New 3-aryl propionic acid derivatives and analogs |
SE9904421D0 (sv) | 1999-12-03 | 1999-12-03 | Astra Ab | New compounds |
SE9904413D0 (sv) | 1999-12-03 | 1999-12-03 | Astra Ab | Comminuted form |
WO2001040165A1 (en) | 1999-12-03 | 2001-06-07 | Astrazeneca Ab | Crystalline form of 3-{4-[2-(4-tert-butoxycarbonylaminophenyl)ethoxy]phenyl}-(s)-2-ethoxy propanoic acid |
ES2215769T3 (es) | 1999-12-03 | 2004-10-16 | Astrazeneca Ab | Forma cristalina de acido (s)-2-etoxi-3-(4-(2-(4-metanosulfoniloxifenil)etoxi)fenil)propanoico. |
TW574193B (en) * | 1999-12-03 | 2004-02-01 | Astrazeneca Ab | Novel phenalkyloxy-phenyl derivatives, pharmaceutical composition containing the same and their uses |
SE9904415D0 (sv) | 1999-12-03 | 1999-12-03 | Astra Ab | New process |
SE9904412D0 (sv) | 1999-12-03 | 1999-12-03 | Astra Ab | Comminuted form |
CA2397828C (en) | 2000-01-19 | 2007-09-04 | Cadila Healthcare Ltd. | Compounds having hypolipidemic and hypocholesteremic activities, process for their preparation and pharmaceutical compositions containing them |
-
1998
- 1998-10-26 US US09/179,141 patent/US6130214A/en not_active Expired - Fee Related
- 1998-10-26 EP EP98955100A patent/EP1124807A1/en not_active Withdrawn
- 1998-10-26 WO PCT/US1998/022569 patent/WO1999016758A1/en not_active Application Discontinuation
- 1998-10-26 CN CN98811663A patent/CN1280574A/zh active Pending
- 1998-10-26 AU AU11986/99A patent/AU1198699A/en not_active Abandoned
- 1998-10-27 AR ARP980105382A patent/AR015470A1/es not_active Application Discontinuation
- 1998-10-27 ZA ZA989790A patent/ZA989790B/xx unknown
- 1998-10-27 MY MYPI98004872A patent/MY121760A/en unknown
-
2000
- 2000-07-05 US US09/610,623 patent/US6331627B1/en not_active Expired - Fee Related
-
2001
- 2001-03-27 US US09/818,339 patent/US6664411B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CN1280574A (zh) | 2001-01-17 |
ZA989790B (en) | 1999-04-28 |
WO1999016758A1 (en) | 1999-04-08 |
US6331627B1 (en) | 2001-12-18 |
US6664411B2 (en) | 2003-12-16 |
MY121760A (en) | 2006-02-28 |
AU1198699A (en) | 1999-04-23 |
US6130214A (en) | 2000-10-10 |
EP1124807A1 (en) | 2001-08-22 |
US20010027198A1 (en) | 2001-10-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR015470A1 (es) | Acido beta-arilo-alfa-alquilcarboxilico, su uso para la manufactura de un medicamento, procedimientos para su preparacion, composiciones farmaceuticas quelos contienen, compuestos intermediarios y procedimiento para su preparacion | |
AR015769A1 (es) | Derivados de imidazo piridina que inhiben la secrecion de acido gastrico, procedimiento para la preparacion de dichos derivados, composicion farmaceutica, uso de dichos derivados para la preparacion de medicamentos, y compuestos intermediarios. | |
ATE172731T1 (de) | Pyrazolopyridinverbindung und verfahren zu ihrer herstellung | |
MX9305379A (es) | Nuevos derivados de aminoacidos, procedimiento para su preparacion y preparado farmaceutico que los contiene. | |
DK0622361T3 (da) | Heterocykliske forbindelser som bradykininantagonister | |
ES2058527T3 (es) | Derivados de pirimidina condensados procedimiento y compuestos intermedios para su preparacion y composiciones farmaceuticas que los contienen. | |
FI962155A0 (fi) | Uudet 9-hydroksipyrido (1,2-a) pyrimidin-4-onieetterijohdannaiset | |
DK362482A (da) | Fremgangsmaade til fremstilling af benzimidazolderivater eller terapeutisk acceptable salte deraf | |
DK57181A (da) | Fremgangsmaade til fremstilling af 4-substituerede imidazolderivater eller ugiftige farmaceutisk acceptable syreadditionssalte deraf | |
IL107869A0 (en) | Benzodiazepine derivatives, their preparation and pharmaceutical compositions containing them | |
ES2118203T3 (es) | Nuevos derivados benzopiranicos, su procedimiento de preparacion y composiciones farmaceuticas que los contienen. | |
NZ515284A (en) | Substituted bicyclic heterocycles, process for their preparation and their use as antiobesity and hypocholesterolemic agents | |
ES2104865T3 (es) | Nuevos derivados de n-ciclohexilbenzamidas, sus preparaciones y sus aplicaciones terapeuticas. | |
ES2063471T3 (es) | Nuevos derivados de guanidina, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen. | |
NO812355L (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 3,1-benzoksazin-2-on-derivater | |
ES2116467T3 (es) | Derivados de 5h,10h-imidazo(1,2-a)indeno(1,2-e)pirazina-4-ona, su preparacion y los medicamentos que les contienen. | |
DK118083D0 (da) | Theophyllinylalkyloxadiazoler eller additionssalte deraf, deres fremstilling og anvendelse som laegemidler | |
AR015469A1 (es) | Acido alquil-carboxilico beta-aril-alfa-oxisubstituido, su uso en la manufactura de un medicamento, procedimiento para su preparacion, composiciones farmaceuticas que los contienen, compuestos intermediarios y procedimiento para su preparacion | |
ATE102199T1 (de) | 4-amino-3-carboxynaphthyridin-derivate, ihre herstellung und pharmazeutische zusammensetzungen. | |
MX9400165A (es) | Derivados de ter-butilergolina, proceso para su produccion y composiciones farmaceuticas que los contienen. | |
ES2136614T3 (es) | Derivados de 1,4-dihidropiridina, su procedimiento de preparacion y composicion terapeutica que los contiene. | |
ATE48999T1 (de) | Piperazin-1-yl-ergolinderivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen. | |
ES2063157T3 (es) | Nuevos derivados del indol, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen. | |
AR005454A1 (es) | Derivados de isooxacefem, su uso, procedimiento para su preparacion y preparaciones farmaceuticas que contienen a dichos derivados. | |
AR015989A1 (es) | Acido alquilcarboxilo beta-aril-alfa-oxisubstituido su uso para la manufactura de un medicamento, procedimiento para su preparacion, composiciones farmaceuticas que los contiene, compuestos intermediarios y procedimiento para su preparacion |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |